• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Manufacturing
    • Packaging
    • Development
    • Compliance
    • Top 25
    • Directory
    • Microsites
    • Events
    • More
  • Magazine
  • News
  • Manufacturing
  • Packaging
  • Development
  • Compliance
  • Top 25
  • Directory
  • Microsites
  • Events
  • Current / Back Issue
    Features
    Editorial
    Columns
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Subscribe Now
    Advertise Now
    Top Features
    Bye-Bye China?

    Decentralized Trials Fuel AI Revolution in Clinical Research

    Self-Medication: Flexibility for Patients and Drug Manufacturers

    The Single-Use Mixing Landscape: Evaluating Your Options

    DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    Breaking News
    Online Exclusives
    Industry News
    Collaborations & Alliances
    Promotions & Moves
    Trials & Filings
    Financial Reports
    Bio News & Views
    Custom Sourcing News
    Packaging & Tracking
    CRO News
    Live From Shows
    Top News
    Valeo Pharma Appoints President, COO

    Metrion, LifeArc Extend Neuroscience Alliance

    Grifols Begins COVID-19 Plasma Treatment Trial

    Janssen, TenNor Enter NTM Research Pact

    KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    APIs
    Aseptic Processing
    Cleaning Validation
    Clinical Trial Materials
    Cytotoxics and High Potency Manufacturing
    Equipment
    Excipients
    Extractables and Leachables
    Facilities
    Fill/Finish
    Lyophilization
    Parenterals
    Process Development
    Process Validation
    Risk Management
    Scale-up/ Technology Transfer
    Solid Dosage/ Creams/ Ointments

    Cognate BioServices Announces Major Expansion

    Sanofi Unveils EUROAPI as Name of New European API Company

    Precision Medicine Group Acquires Project Farma

    Cytiva Delivers Modular Biologics Factory to Lonza

    Fujifilm, CABIM Get $76M Funding for Mfg. and Innovation Center
    Capsules
    Cold Chain Management
    Injectables
    Logistics
    Serialization
    Solid Dosage / Semi-solids
    Supply Chain
    Vials

    Catalent Acquires Acorda’s INBRIJA Manufacturing Operations

    Varcode, PL Developments Form Strategic ‘Smart Tag’ Pact

    COVID-19 Vaccine Distribution: The Air Cargo Industry’s Greatest Challenge

    Thermo Fisher Expands Clinical Supply Services in Europe

    Schreiner MediPharm Joins DoseID Consortium
    Analytical Services
    Bioanalytical Services
    Bioassay Developement
    Biologics, Proteins, Vaccines
    Biosimilars
    Chemistry
    Clinical Trials
    Drug Delivery
    Drug Development
    Drug Discovery
    Formulation Development
    Information Technology
    Laboratory Testing
    Methods Development
    Microbiology
    Preclinical Outsourcing
    R&D
    Toxicology

    Metrion, LifeArc Extend Neuroscience Alliance

    Grifols Begins COVID-19 Plasma Treatment Trial

    Janssen, TenNor Enter NTM Research Pact

    Virtual Clinical Trials: The Future of Dermatology Studies

    Cognate BioServices Announces Major Expansion
    Filtration & Purification
    GMPs/GCPs
    Inspections
    QA/QC
    Regulatory Affairs
    Validation

    Gene Therapy Co. Selects ValGenesis' SaaS Platform

    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021

    Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management

    CDMO Cognate BioServices Teams Up with L7 Informatics

    The Wasdell Group Earns ISO 13485 Certification
    Companies
    Categories
    Corporate Capabilities
    Add New Company
    Contract Service Directory Companies
    Reed-Lane

    Cytovance Biologics

    Emergent BioSolutions

    Adare Pharma Solutions

    PCI Pharma Services
    Companies
    News Releases
    Posters
    Brochures
    Services
    Videos
    Case Study
    White Papers
    Jobs
    Contract Service Directory Companies
    Alcami

    Adare Pharma Solutions

    Baxter BioPharma Solutions

    Aphena Pharma Solutions

    PCI Pharma Services
    Webinars
    Live From Shows
    • Magazine
      • Current / Back Issue
      • Features
      • Editorial
      • Columns
      • Editorial Guidelines
      • Subscribe Now
      • Advertise Now
      • Enewsletter Archive
      • Digital Edition
    • Directory
      • Companies
      • Categories
      • Corporate Capabilities
      • Add Your Company
    • Manufacturing
      • APIs
      • Aseptic Processing
      • Cleaning Validation
      • Clinical Trial Materials
      • Cytotoxics and High Potency Manufacturing
      • Equipment
      • Excipients
      • Extractables and Leachables
      • Facilities
      • Fill/Finish
      • Lyophilization
      • Parenterals
      • Process Development
      • Process Validation
      • Risk Management
      • Scale-up/ Technology Transfer
      • Solid Dosage/ Creams/ Ointments
      • cGMP Manufacture
    • Packaging
      • Capsules
      • Cold Chain Management
      • Injectables
      • Logistics
      • Serialization
      • Solid Dosage / Semi-solids
      • Supply Chain
      • Vials
    • Development
      • Analytical Services
      • Bioanalytical Services
      • Bioassay Developement
      • Biologics, Proteins, Vaccines
      • Biosimilars
      • Chemistry
      • Clinical Trials
      • Drug Delivery
      • Drug Development
      • Drug Discovery
      • Formulation Development
      • Information Technology
      • Laboratory Testing
      • Methods Development
      • Microbiology
      • Preclinical Outsourcing
      • R&D
      • Toxicology
    • Compliance
      • Filtration & Purification
      • GMPs/GCPs
      • Inspections
      • QA/QC
      • Regulatory Affairs
      • Validation
    • Top 25 Pharma & BioPharma
    • Contract Pharma Direct
    • Breaking News
    • Online Exclusives
    • Slideshows
    • Experts Opinions
    • Surveys
      • Outsourcing Survey
      • Salary Survey
    • Glossary
    • Videos
    • Podcasts
    • White Papers
    • Infographics
    • Contract Pharma Conference
      • Contract Pharma Conference
      • Speakers
      • Exhibitors
      • Conference Sessions
    • Supplier Microsite
      • Companies
      • News Releases
      • Posters
      • Brochures
      • Services
      • Videos
      • Case Study
      • White Papers
    • eBook
    • Webinars
    • Events
      • Industry Events
      • Live from Show Events
      • Webinars
    • Classifieds / Job Bank
      • Classifieds
      • Job Bank
    • About Us
      • About Us
      • Contact Us
      • Advertise With Us
      • Privacy Policy
      • Terms of Use
    India Report

    Injectables Firms Expand Capacity

    CDMOs see steriles demand grow.

    Injectables Firms Expand Capacity
    Related CONTENT
    • Aurigene Pharmaceutical Services ltd.
    • The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    • Tjoapack Invests $12.1M in Packaging & Supply Chain Facility
    • Reed-Lane Adds Second Track & Trace Cartoning Line
    • Erfo
    S. Harachand, Contributing Editor11.17.20
    When the Securities and Exchange Board of India (SEBI) gave its nod to the injectables-firm Gland Pharma to launch an initial public offer (IPO) in late October, the news came as nothing less than a silver lining on the horizon of an industry which is overcast by the protracted pandemic clouds.

    The tidings infused a fresh bout of vigor not only to the contract development and manufacturing organizations (CDMOs) dealing with sterile injectables but to the entire pharmaceutical industry, as well. The pharma sector was receiving such news from India’s regulator of the securities and commodity markets after a gap of over three years.

    Reports said the company and its shareholders were planning to raise as much as 64.5 billion rupees ($871 million) from the capital market by selling as many as 43.2 million shares in the offering. The IPO so far was the biggest by a pharmaceutical firm in India. The $260 million share sales by Eris Lifesciences in 2017 set the record in this sector. Gland’s was also the country’s second-biggest IPO in the year 2020 after a $1.44 billion offering by SBI Cards.

    Gland Pharma is backed by Shanghai Fosun Pharmaceutical (Group) Co. The Chinese company acquired a 74% stake in the Hyderabad-based firm for about $1.1 billion in 2017.

    Gland Pharma is a pure-play sterile injectables manufacturer with a portfolio of products across various therapeutic segments such as anti-diabetic, anti-infectives, anti-malarials, anti-neoplastics, ophthalmics, cardiac, gastrointestinal and hormones through a combination of delivery systems including liquid vials, lyophilized vials, pre-filled syringes, ampoules, bags and drops.

    According to the company website, Gland Pharma is enabled to meet diverse injectable product needs across a vast range of specific requirements with 22 production lines for finished formulations across four facilities. Three of its factories are dedicated to API production. This backward integration eliminates the uncertainty of APIs and allows the company to achieve greater control over manufacturing, operating efficiencies, product development, quality control and supply chain. The company is planning to augment its manufacturing capacity of approximately 750 million units in the medium term.

    The formulation manufacturing facilities, which use aseptic filling or terminal sterilization, are equipped for production flexibility and can switch product lines seamlessly, obviating the need to install additional production lines to meet altered product specifications and market demand.

    With expertise in the synthesis of complex drug molecules such as low-molecular-weight heparin (LMWH), corticosteroids, peptides and cytotoxic molecules, the company has secured several product approvals from various regulators including U.S. FDA and UK MHRA.

    The bulk of Gland’s revenues come from the U.S. and EU markets even though the company currently exports injectables and other sterile products to over 60 countries. In 2019-20, about two-thirds of its earnings were posted from the U.S. market. Gland Pharma is one of the fastest-growing companies in the segment by revenue in the U.S. from 2014 to 2019, as per the company’s filing.

    Gland Pharma said the proceeds from IPO would be used for Capex and working capital for its Indian operations. The company plans to expand its manufacturing capacity and add more products to its pipeline.

    Experts see targeted investments happening in the future in sterile injectable contract manufacturing organizations (CMOs) as the demand for the generic injectable products grows.

    The global generic sterile injectables market is estimated to reach $196.2 billion by 2029 with a CAGR of 11.2% during the forecast period, says a report by Prophecy Market Insights.

    Casting an eye on the faster clip growth, companies are expanding their product offerings and manufacturing capacities.

    Biological E, a biopharmaceuticals firm, announced the acquisition of Akorn India Ltd., a subsidiary of U.S.-based Akorn Inc. to boost the Hyderabad-based company’s manufacturing capacity in August. Akorn India’s facility at Paonta Sahib in Himachal Pradesh has a sterile injectables plant with an annual capacity to manufacture nearly 135 million units and has the potential to immediately expand by a further 30 million units. 

    The buyout is expected to give a fillip to Biological E as the company has a manufacturing agreement with Janssen Pharmaceutica NV of Johnson & Johnson for its COVID-19 vaccine candidate which is currently in phase 1 and 2 clinical trials. 

    Late last year, Strides Pharma Science said that the company was making an additional investment in Stelis Biopharma Private Ltd., an injectables CMO-based in Bangalore. Strides, which sold its injectables business to Mylan in a $1.6 billion deal in 2013, is planning a re-entry into the steriles manufacturing space, the company said.


    S. Harachand
    Contributing Editor

    S. Harachand is a pharmaceutical journalist based in Mumbai. He can be reached at harachand@gmail.com.
    Suggested For You
    Aurigene Pharmaceutical Services ltd. Aurigene Pharmaceutical Services ltd.
    The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021 The Year of COVID: How FDA Coped with a Worldwide Pandemic in 2020 and What to Expect in 2021
    Tjoapack Invests $12.1M in Packaging & Supply Chain Facility Tjoapack Invests $12.1M in Packaging & Supply Chain Facility
    Reed-Lane Adds Second Track & Trace Cartoning Line Reed-Lane Adds Second Track & Trace Cartoning Line
    Erfo Erfo
    Asymchem Asymchem
    Bormioli Pharma Acquires ISO GmbH Bormioli Pharma Acquires ISO GmbH
    Lonza Capsules and Health Ingredients Lonza Capsules and Health Ingredients
    PCI Pharma Services PCI Pharma Services
    Catalent Pharma Solutions Catalent Pharma Solutions
    August Bioservices Expands Operations in Nashville August Bioservices Expands Operations in Nashville
    Delpharm to Manufacture Pfizer/BioNTech mRNA Vax in France Delpharm to Manufacture Pfizer/BioNTech mRNA Vax in France
    Asahi Kasei Pharma Contracts ProBioGen Asahi Kasei Pharma Contracts ProBioGen
    Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study Pfizer, BioNTech Conclude Phase III COVID-19 Vax Study
    Inspecting the Unexpected Inspecting the Unexpected

    Related India Report

    • Supply Chain Woes Vex Markets

      Supply Chain Woes Vex Markets

      Indian players ramp up chloroquine production
      S. Harachand, Contributing Editor 09.09.20

    • HCQ Comes Center Stage

      HCQ Comes Center Stage

      Indian players ramp up chloroquine production
      S. Harachand, Contributing Editor 05.05.20

    • Supply Chain
      Oral Solids Makers Face Corona Heat

      Oral Solids Makers Face Corona Heat

      CDMOs fear supply disruptions, price increases.
      S. Harachand, Contributing Editor 03.04.20


    • Biosimilars
      The Similar Mantra

      The Similar Mantra

      Early birds bet big on biosimilars.
      S. Harachand, Contributing Editor 01.28.20

    • APIs
      India to Track API Packs

      India to Track API Packs

      India is mulling a shakeup in the regulations governing the distribution of pharmaceutical products.
      S. Harachand, Contributing Editor 11.20.19

    • R&D
      Indian Firms Ramp Up R&D

      Indian Firms Ramp Up R&D

      Accelerating on research spend.
      S. Harachand, Contributing Editor 10.15.19


    • Cytotoxics and High Potency Manufacturing
      Highly Potent Expansions

      Highly Potent Expansions

      CDMOs see HPAPI demand rising
      S. Harachand, Contributing Editor 09.16.19

    • The Orphan Promise

      The Orphan Promise

      New policy on rare disease treatments likely soon
      S. Harachand, Contributing Editor 06.13.19

    • Biologics, Proteins, Vaccines
      Ebullient Bio CMOs

      Ebullient Bio CMOs

      Firms see rich dividends from biosimilars
      S. Harachand, Contributing Editor 05.07.19


    • R&D
      Strategic Discovery

      Strategic Discovery

      CROs top offerings with biology skills.
      S. Harachand , Contributing Editor 10.10.18

    • HPAPI Outsourcing Likely to Gain Traction

      HPAPI Outsourcing Likely to Gain Traction

      A number of highly potent drugs will soon fall into the generic domain
      S. Harachand, Contributing Editor 09.11.18

    • Packaging Majors Expand Base in India

      Packaging Majors Expand Base in India

      India’s pharma packaging market is growing at a faster pace than other world markets
      S. Harachand, Contributing Editor 03.09.18


    • Acquisition Spree

      Acquisition Spree

      Indian firms topped the list of aggressive bidders even as the frenzy of deal making in the global generics space passes into
      S. Harachand, Contributing Editor 01.30.18

    • Drug Delivery
      Growing NDDS Portfolios

      Growing NDDS Portfolios

      Generic drugs on novel delivery platforms
      S. Harachand, Contributing Editor 10.11.17

    • Supply Chain
      Marketing Code Round The Corner

      Marketing Code Round The Corner

      Proposal to limit giveaways; offenders face product ban
      S. Harachand, Contributing Editor 09.01.17

    Trending
    • Fujifilm To Invest $2B In US Manufacturing Site
    • Roche Canada To Invest $500M To Create 500 Jobs In Ontario
    • Tonix And Fujifilm Enter COVID-19 Vax Deal
    • Virtual Clinical Trials: The Future Of Dermatology Studies
    • Sanofi Unveils EUROAPI As Name Of New European API Company
    Breaking News
    • Valeo Pharma Appoints President, COO
    • Metrion, LifeArc Extend Neuroscience Alliance
    • Grifols Begins COVID-19 Plasma Treatment Trial
    • Janssen, TenNor Enter NTM Research Pact
    • KORSCH, MEDELPHARM Partner on R&D Equipment Portfolio
    View Breaking News >
    CURRENT ISSUE

    November/December 2020

    • Modeling Process Safety Workflows in Pharmaceutical Manufacturing Scale-Up
    • Ensuring Quality During the Transfer and Scale Up of Rx Drugs
    • Inspecting the Unexpected
    • Cold Chain Trends
    • Catering for the Complex
    • Biopharma Contract Manufacturing: Robust Growth Ahead
    • DCAT President Talks COVID-19, Drug Manufacturing and Innovation
    • The Single-Use Mixing Landscape: Evaluating Your Options
    • Self-Medication: Flexibility for Patients and Drug Manufacturers
    • Decentralized Trials Fuel AI Revolution in Clinical Research
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    Maternal Dietary Intake of Fish, Omega-3s, and Omega-6s Linked to Child Neurodevelopment
    Short Term Low-Carb Diet Linked to Remission of Type 2 Diabetes
    Brown Fat Associated with Reductions in Chronic Disease Risk
    Coatings World

    Latest Breaking News From Coatings World

    Huntsman Finalizes Acquisition of Gabriel Performance Products
    PPG Completes COLORFUL COMMUNITIES Project at School in A. Bangsaothong Samutprakarn, Thailand
    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    FineHeart Successfully Tests Wireless TET System
    Apria Healthcare Settles Whistleblower Lawsuit
    OraSure’s OMNIgene·ORAL Device Included in COVID-19 EUA Amendment
    Contract Pharma

    Latest Breaking News From Contract Pharma

    Valeo Pharma Appoints President, COO
    Metrion, LifeArc Extend Neuroscience Alliance
    Grifols Begins COVID-19 Plasma Treatment Trial
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    JLo Beauty Launches at Sephora & Amazon
    Unilever and Alibaba Group Join Forces
    Redken Unveils Acidic Bonding Concentrate Range
    Happi

    Latest Breaking News From Happi

    A Surge in Interest for Supplements & Vitamins
    Manscaped Expands Further in Europe
    Color Street Gives Back
    Ink World

    Latest Breaking News From Ink World

    dar-tech, inc. Becomes U.S. Midwestern Distributor for ZS Interpolymer
    Techkon USA, Konica Minolta Partner
    Alon Bar-Shany Appointed Chairman of Highcon Board
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Exhibitor registration opens for virtual.drupa
    FTA planning in-person Forum & INFOFLEX
    Fortis Solutions Group achieves SGP certification
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Ontex Honored for Mask Production
    TFP Acquires PV3 Technologies
    Shemesh Adds U.S. Headquarters
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    OrthoPediatrics Expands Agent Network in Three European Countries
    Studies Show FlareHawk Expandable Cage Delivers Favorable Fusion, Patient Outcomes
    Rapid Recovery Protocol Can Lead to Increased Range of Motion After TKA
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    UDC Subsidiary Adesis' Website Wins 2020 MarCom Platinum Award
    Roadsimple Modernizes Warehouse Ops with Zebra Technologies
    Graphene Flagship Launches Redesigned Website

    Copyright © 2021 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login